Not Signed In - Atherosclerosis Phase 2 Clinical Milestone Of MK-0354
Fri, 19 May 2006 06:00 AM EST
... Pharmaceuticals, Inc.(Nasdaq: ARNA) announced today the initiation of a Phase 2 clinical trialof MK-0354, an Arena discovered orally administered drug candidate underdevelopment by Merck for the treatment of atherosclerosis and relateddisorders. [click link for full article] ...
Related Topics
- Atherosclerosis
- Clinical Trials
- Pharmacology
- Psychopharmacology
- Arteriosclerosis/Atherosclerosis
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Clinical Growth Charts
- Menkes syndrome
- Speech and Language: Developmental Milestones
- Hypnotherapy
- Epidemiology
- Clinical Laboratory Improvement Amendments
- Depression
- Infectious Diseases
- Western/Clinical Treatment and Therapy
- Epidemiology & Prevention of Vaccine-Preventable Diseases
- Child Development
- Trastuzumab
- Tarceva
email this page
print this page
bookmark this page
feedback on this page
